Építés alatt – nem éles oldal
Belépés
Még nem keres résztvevőt itt: KínaFázis nélkül

Artificial Intelligence-Assisted Care After Hospital Discharge for People With Decompensated Cirrhosis

A legfontosabb adatok

Ki végzi
Beijing Tsinghua Chang Gung Hospital
Hol
Beijing (Kína)A helyszín megnézése
Azonosító
Állapot
Toborzás még nem indult
Résztvevők
180 fő, tervezett
Kezdés
2026. nov. 30.
Várható befejezés
2028. febr. 29.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • AI Agent-Assisted Proactive Management
  • Standard Care
A regiszteradat frissítve
2026. november 12.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with cirrhosis (severe scarring of the liver) who were in hospital for liver complications and are ready to go home. It compares usual care with usual care plus an AI-assisted follow-up service for 90 days.

Életkor
18 years or older, with no upper age limit.
Nem
All sexes can join.
A betegség stádiuma
Decompensated cirrhosis, confirmed by a liver specialist. The hospital stay must be linked to it, for example fluid in the belly (ascites), brain confusion from liver disease, or bleeding from swollen veins. People with earlier decompensation who were in hospital for infection, worsening kidney function or other related problems can also join.
Korábbi kezelés
People must currently be in hospital and ready for discharge.

A részvétel fő kizáró okai

  • Lasting severe problems with awareness or thinking that stop the person from giving consent alone.
  • Receiving end-of-life care, or the care team thinks taking part would be too heavy a burden.
  • No way to be contacted, or no help available to take part.
  • Taking part in another treatment study that clearly conflicts with this one.
  • Upcoming hospital stays mainly due to tumour growth or planned cancer treatment.

A regiszter feltételei, szó szerint

Mind a 10 feltétel megnézéseKevesebb

Ki vehet részt

  • Aged 18 years or older on the date of signing the informed consent form, with no upper age limit; cirrhosis confirmed by a hepatologist based on clinical findings, laboratory tests, imaging and/or endoscopy, and histopathology when necessary
  • The index hospitalization is related to decompensated cirrhosis or associated complications, with evidence of decompensation such as ascites, overt hepatic encephalopathy, or variceal bleeding, or hospitalization for infection, worsening renal function, or other related complications in a patient with previous decompensation; the patient currently meets the criteria for discharge
  • Plans to return home or to an out-of-hospital setting that supports follow-up, with randomization completed on the day of discharge before initiation of the intervention and the 90-day observation period beginning at discharge
  • Is alert and has the capacity to understand the study and independently provide informed consent; the participant or an authorized reliable caregiver can complete mobile reporting or telephone-assisted data entry as permitted by the study
  • Voluntarily provides written informed consent and separate consent for necessary data processing, and agrees to 90-day outcome ascertainment conducted at the same frequency in both study groups

Ki nem vehet részt

  • Receiving end-of-life care, or participation is considered to impose a clearly disproportionate burden by the treating clinical team
  • Concurrent participation in another interventional study that clearly conflicts with this study
  • Persistent severe impairment of consciousness or cognition that prevents the participant from independently providing informed consent
  • No feasible means of contact, or inability to obtain the assistance necessary for study participation
  • Near-term hospitalizations are primarily driven by tumor progression or planned oncological treatment, such that cirrhosis-related outcomes cannot be reliably distinguished from tumor-related care

Helyszínek itt: Kína

  • Beijing Tsinghua Changgung HospitalBeijing, KínaContact: Dongliang ZhaoToborzás még nem indult

A vizsgálatról

Mit akar kideríteni a vizsgálat

This study will compare two ways of supporting adults with cirrhosis after they leave hospital. Cirrhosis is severe scarring of the liver. Eligible participants will have been hospitalized for liver-related complications and will be ready for discharge. The main question is whether adding an artificial intelligence (AI)-assisted management service to usual care reduces unplanned hospital care caused by worsening liver disease during the next 90 days.

A teljes eredeti leírásKevesebb

The study plans to enroll 180 adults at three centers. Participants will be assigned by chance, with an equal chance of receiving usual care alone or usual care plus AI-assisted proactive management. Participants receiving the additional service, or their authorized caregivers, will complete a brief daily health report taking about 3-5 minutes and may report symptoms when they occur. The system helps organize reports and identify information requiring attention. Nurses check the information, and physicians make clinical decisions. The system does not independently diagnose illness, prescribe treatment, or change medication.

Both groups will continue their usual medical care and have study follow-up contacts on days 7, 30, 60, and 90. The study will compare unplanned emergency visits, hospital observation, acute same-day treatment, and readmissions related to worsening liver disease. Safety and the burden of using and delivering the service will also be assessed. Participants with urgent symptoms should seek emergency care without waiting for a response from the study platform.

A vizsgálat 2 csoportja

  • AI Agent-Assisted Proactive Management Plus Standard CareA vizsgált kezelés

    Participants will receive standard care plus 90 days of AI agent-assisted proactive management after discharge. Participants or authorized caregivers will submit brief daily health reports and may report symptoms as they occur. The service combines AI-supported information structuring, rules-based risk alerts, nurse verification, physician-led clinical decisions, and documentation of actions and follow-up.

    Kezelés: AI Agent-Assisted Proactive Management és Standard Care

  • Standard CareMár használt kezelés, összehasonlításként

    Participants will receive standard care without access to the study AI agent-assisted proactive management service. Existing outpatient care, telephone follow-up, clinical contact channels, and access to emergency care will be maintained. Scheduled study outcome ascertainment and safety follow-up will be performed at the same frequency as in the experimental group.

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Development and Evaluation of an AI Agent-Assisted Proactive Postdischarge Management Model for Patients With Decompensated Cirrhosis
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. november 12.